Key result
Sodium nitroprusside yielded favorable haemodynamic responses in 14 of 22 treatment occasions, which appeared limited to patients with high systemic vascular resistance (>1900 dynes s cm-5).
Why the study?
Does sodium nitroprusside improve clinical and haemodynamic indices in patients with severe refractory congestive heart failure?
Observational (n=21)
Does sodium nitroprusside improve clinical and haemodynamic indices in patients with severe refractory congestive heart failure?
The favourable haemodynamic response to sodium nitroprusside in severe congestive heart failure appears to be limited to patients with a high baseline systemic vascular resistance (>1900 dynes s cm-5).
Answers are grounded in this paper and cite their sources.
Nitroprusside response varies in refractory HF with hypotension risk; leaves open validation of baseline pressure predictors.
Twenty-one patients in severe congestive heart failure refractory to conventional medical management were treated with sodium nitroprusside on 22 occasions. On 14 occasions (responders) there was significant improvement in clinical and haemodynamic indices. On 8 occasions (non-responders) hypotension developed without haemodynamic improvement and nitroprusside treatment had to be abandoned. The initial mean arterial pressure and the capillary wedge pressure tended to be higher in the responders while the cardiac index tended to be higher in the non-responders. The systemic vascular resistance was higher in the responders than in the non-responders (2560 +/- 160 vs 1800 +/- 180 dynes s cm-5, P less than 0.001). All of the responders had systemic vascular resistance greater than 1900 dynes s cm-5, while only one of the non-responders had a systemic vascular resistance in this range. Thus, a variable response to vasodilator therapy for congestive cardiac failure is documented. The favourable response appears to be limited to patients with a high systemic vascular resistance.
No takes yet. Share an insight, caveat, or question.
Lukes et al. (1979) conducted an observational in Severe congestive heart failure refractory to conventional medical management (n=21). Sodium nitroprusside was evaluated on Clinical and haemodynamic improvement. Sodium nitroprusside yielded favorable haemodynamic responses in 14 of 22 treatment occasions, which appeared limited to patients with high systemic vascular resistance (>1900 dynes s cm-5).
Synapse has enriched 10 related papers. Consider them for comparative context: